WO2007052152A3 - Sertraline oral concentrate - Google Patents

Sertraline oral concentrate Download PDF

Info

Publication number
WO2007052152A3
WO2007052152A3 PCT/IB2006/003202 IB2006003202W WO2007052152A3 WO 2007052152 A3 WO2007052152 A3 WO 2007052152A3 IB 2006003202 W IB2006003202 W IB 2006003202W WO 2007052152 A3 WO2007052152 A3 WO 2007052152A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral concentrate
sertraline oral
sertraline
relates
present
Prior art date
Application number
PCT/IB2006/003202
Other languages
French (fr)
Other versions
WO2007052152A2 (en
Inventor
Umesh Setty
Mohinder Paul Pakhetra
Ashish Gogia
Sivakumaran Meenakshisunderam
Original Assignee
Aurobindo Pharma Ltd
Umesh Setty
Mohinder Paul Pakhetra
Ashish Gogia
Sivakumaran Meenakshisunderam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd, Umesh Setty, Mohinder Paul Pakhetra, Ashish Gogia, Sivakumaran Meenakshisunderam filed Critical Aurobindo Pharma Ltd
Publication of WO2007052152A2 publication Critical patent/WO2007052152A2/en
Publication of WO2007052152A3 publication Critical patent/WO2007052152A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to stable oral concentrate composition comprising antidepressant. More particularly, the present invention relates to oral concentrate composition comprising sertraline hydrochloride and one or more pharmaceutically acceptable excipients, wherein the composition contains more than 40%w/w of water.
PCT/IB2006/003202 2005-11-07 2006-10-31 Sertraline oral concentrate WO2007052152A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1610CH2005 2005-11-07
IN1610/CHE/2005 2005-11-07

Publications (2)

Publication Number Publication Date
WO2007052152A2 WO2007052152A2 (en) 2007-05-10
WO2007052152A3 true WO2007052152A3 (en) 2007-10-04

Family

ID=38006255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/003202 WO2007052152A2 (en) 2005-11-07 2006-10-31 Sertraline oral concentrate

Country Status (1)

Country Link
WO (1) WO2007052152A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021521A2 (en) * 1998-10-13 2000-04-20 Pfizer Products Inc. Sertraline oral concentrate
WO2002069888A2 (en) * 2001-02-16 2002-09-12 Andrx Corporation Serotonin reuptake inhibitor formulations
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
WO2005034910A1 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Oral liquid pharmaceutical compositions of sertraline

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
WO2000021521A2 (en) * 1998-10-13 2000-04-20 Pfizer Products Inc. Sertraline oral concentrate
WO2002069888A2 (en) * 2001-02-16 2002-09-12 Andrx Corporation Serotonin reuptake inhibitor formulations
WO2005034910A1 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Oral liquid pharmaceutical compositions of sertraline

Also Published As

Publication number Publication date
WO2007052152A2 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
ME03786B (en) Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2006069363A3 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
EP2311488A3 (en) Vaccine composition
IL163366A (en) Glucocorticoid mimetics, pharmaceutical compositions thereof and uses thereof for the preparation of pharmaceutical compositions
WO2007024949A3 (en) Alpha2c adrenoreceptor agonists
RS20050392A (en) Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
HK1129581A1 (en)
MY154909A (en) Novel thiophene derivatives
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
WO2006024479A3 (en) Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
UA90130C2 (en) Amorphous lercanidipine hydrochloride and pharmaceutical composition based thereon
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
WO2006091836A8 (en) Formulations of ladostigil tartrate
EP1624880A4 (en) Annatto extract compositions, including geranyl geraniols and methods of use
WO2007144699A3 (en) Process for the preparation of alfuzosin
WO2004110364A3 (en) Thiotungstate analogues and uses thereof
WO2007100668A3 (en) Antidepressant prodrugs
WO2006004613A3 (en) Guanylhydrazone salts, compositions, processes of making and methods of using

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06809221

Country of ref document: EP

Kind code of ref document: A2